A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia

Overview of attention for article published in The journal of nutrition, health & aging, June 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 1 news outlet
twitter: 6 X users
patent: 1 patent

facebook: 1 Facebook page
wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 140 Dimensions

Readers on

mendeley: 253 Mendeley

Summary News X Patents Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 news story.

New Options Explored for Sarcopenia in Rheumatic Diseases

Medscape, 18 Aug 2021

New efforts — including the development of drugs that target mitochondrial pathways and others that target androgen receptors…